TIL (Cefuroxime) tablet is indicated in the treatment of
Upper respiratory tract infections
such as otitis media, sinusitis, tonsillitis and pharyngitis caused by M.catarrhalis, S.pyogenes,best replica watches
S.pneumoniae or S.influenzae.
Lower respiratory tract infections
such as acute bronchitis, acute exacerbations of
chronic bronchitis and pneumonia caused by Streptococcus pneumoniae, Haemophilus
Skin and soft tissue infections
such as furunculosis, pyoderma, and impetigo caused by
Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains),
Urinary tract infections
: such as pyelonephritis, urethritis, and cystitis caused by
Escherichia coli and Klebsiella spp.
Uncomplicated gonorrhoea, urethral & endocervical
caused by Neisseria gonorrhoeae.
Early Lyme disease and subsequent prevention of late Lyme disease
caused by Borrelia
TIL (Cefuroxime) should be administered with meals.
||250 mg 12 hrly
|Acute exacerbations of chronic bronchitis
||250 or 500 mg 12 hrly
|Uncomplicated skin and soft tissue infections
|| 250 or 500 mg 12 hrly
| Uncomplicated urinary tract infections
|| 125 or 250 mg 12 hrly
|| 7-10 days
|Early Lyme disease ( Adult & children)
||500 mg 12 hrly
Children : over 3 months of age : 125 mg 12 hourly or 10 mg/kg 12 hourly to a maximum
of 250 mg daily.
over 2 years of age with otitis media : 250 mg 12 hourly or 15 mg/kg 12
hourly to a maximum of 500 mg daily.
In renal impairment : As Cefuroxime's half-life is prolonged in renal impairment, doses of
Cefuroxime should be adjusted.